
| Salt Composition: | Cefpodoxime Proxetil (100mg) + Clavulanic Acid (62.5mg) |
| Manufacturer: | Cipla Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Cefoprox CV 100mg/62.5mg Dry Syrup Mango is a combination of two medicines used to treat respiratory tract infections. Cefoprox CV 100mg/62.5mg Dry Syrup Mango is a prescription medicine. It is advised to take it as per the prescription. It can be taken with or without food but it must be taken at a fixed time to ensure better efficacy. Do not consume more than the recommended dose as this may have harmful effects on your body. If you miss a dose, take it as soon as you remember. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine.
Cefoprox CV 100mg/62.5mg Dry Syrup Mango is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Dissolve the powder in sterile water. Shake well and use. Cefoprox CV 100mg/62.5mg Dry Syrup Mango may be taken with or without food but it is better to take it at a fixed time.
Alcohol
It is not known whether it is safe to consume alcohol with Cefoprox CV 100mg/62.5mg Dry Syrup Mango. Please consult your doctor.
Breastfeed
Cefoprox CV 100mg/62.5mg Dry Syrup Mango is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Cefoprox CV 100mg/62.5mg Dry Syrup Mango is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.